It used to be simple. You'd meet someone, go on a date, share a pizza and a bottle of red, then end the night tangled in the ...

North Yorkshire Police has launched an investigation after a woman ended up in intensive care after using a weight-loss jab ...

Adverse reactions to the likes of Ozempic and Wegovy are set to soar by more than 350% in a single year, according to the latest data. Between January and mid-May 2024, some 2,780 reports of ...

A number of patients, including at least three from Long Island, contend they suddenly lost their vision after taking the widely popular weight loss drugs Ozempic and Wegovy, according to a Long ...

In 2022, the FDA opened the door, allowing teens 12 years and older to be prescribed Semaglutide, it’s the active ingredient in Ozempic and Wegovy. Semaglutide dispense rate increased by 594% ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer. By Rebecca Robbins Novo Nordisk will replace its ...

Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic and Wegovy, as well as tirzepatide injections Zepbound and Mounjaro ...

Such good fortune is affecting the companies which make them. Ozempic and Wegovy maker Novo Nordisk this week released its Q1 earnings, and it’s clear that GLP-1s are driving profits. Sales for the ...